A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...

The findings could lead to genetic tests that predict the likelihood of disease recurrence in breast cancer patients and ...

Drinking alcohol if you have a large belly or diabetes more than doubles the risk of serious liver damage, while having high ...

Given the latest data, which includes troubling trends in pancreatic cancer and growing inequities in cancer outcomes for ...

Liver cancer is uncommon in the United States, but it is common worldwide due to risk factors such as chronic hepatitis B and C infections and exposure to aflatoxin (toxins produced by a certain ...

Liver cancer is a type of cancer with a recurrence rate of 70% even after surgical removal of cancer cells. As a result, it is the second leading caus... Seoul National University Hospital leads ...

Salk Institute researchers found that regulating bile acids—specifically reducing harmful ones and increasing UDCA—can enhance T cell function and potentially make immunotherapy more effective for ...

Lung cancer liver metastases are tumors that form in the liver from cancer cells that have broken away from the primary cancer and spread through the blood or lymphatic system. The liver is a common ...

A nurse, left "devastated" by her diagnosis, has bravely come forward to share the four warning signs that led to the discovery of her liver cancer. Marissa Antonio was only 39 when doctors found ...

This effect increases the risk of cancer in the mouth and throat, in particular. Compared with cancers of the mouth, throat and liver, the link between alcohol and cancers of the colon and rectum ...

"Based on data from the eight eligible studies from 2019 to 2023, the committee concludes that compared with never consuming alcohol, moderate alcohol consumption is associated with lower all-cause ...

Long classified as a subset of common liver cancer, FLC should be considered its own unique disease. Now researchers are testing a combination drug therapy that targets FLC tumors. Like many rare ...